NCT00810979View on ClinicalTrials.gov

Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia

PHASE2CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Hyperlipidemia
Interventions
DRUG

SLx-4090

tablet

DRUG

SLx-4090

tablet

OTHER

Placebo

matching tablet

DRUG

Statin

Subjects were dosed with the statin prescribed specifically by their prescribing physician.

Trial Locations (19)

14609

Rochester

23294

Richmond

27609

Raleigh

29464

Mt. Pleasant

30342

Atlanta

32205

Jacksonville

35209

Birmingham

40213

Louisville

44122

Cleveland

45212

Cincinnati

45219

Cincinnati

46260

Indianapolis

55435

Edina

60101

Addison

60611

Chicago

60654

Chicago

63141

St Louis

85282

Tempe

85710

Tucson

Sponsors
All Listed Sponsors
lead

Response Pharmaceuticals

INDUSTRY

NCT00810979 - Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia | Biotech Hunter | Biotech Hunter